This Symposium will be hosted live and available on-demand
October 20-21, 2026
11:00 AM - 3:00 PM ET
Three-dimensional (3D) organoid models are transforming biomedical research by providing physiologically relevant systems that more closely mimic human tissues than conventional cell culture models. Derived from stem cells or primary tissues, organoids enable researchers to investigate tissue development, model disease progression, evaluate therapeutic responses, and better understand the molecular mechanisms that drive human health and disease.
In this symposium, leading researchers will discuss how tissue-specific organoid models are advancing disease modeling across a wide range of biological systems. Sessions will explore recent advances in organoid generation, stem cell biology, disease mechanism research, regenerative medicine, and drug discovery while highlighting how increasingly sophisticated 3D culture platforms are improving translational research and supporting more predictive experimental models.
Topics to be covered
- Developing tissue-specific organoid models for disease research
- Using organoids to investigate disease mechanisms and tissue development
- Advances in stem cell biology and 3D culture technologies
- Applications of organoids in drug discovery and therapeutic screening
- Translating organoid research into regenerative medicine and precision medicine
 |
Yisu Wang, PhD
|
 |
Marcus Bunn, PhD
|
 |
Lindy O’Clair
|
